US Psoriasis Market and Competitive Landscape Highlights - 2016

  • ID: 3679594
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Psoriasis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Psoriasis pipeline products, Psoriasis epidemiology, Psoriasis market valuations and forecast, Psoriasis products sales and competitive landscape in the US.

The research is classified into nine sections – Psoriasis overview including etiology, pathophysiology, and diagnosis, Psoriasis treatment options, Psoriasis pipeline products, Psoriasis market analysis comprising of Psoriasis epidemiology, key products marketed for Psoriasis, market valuations and forecast, products sales and market shares.

Research Scope:
- Psoriasis Pipeline: Find out the products in clinical trials for the treatment of Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Psoriasis Epidemiology: Find out the number of patients diagnosed (prevalence) with Psoriasis in the US
- Psoriasis Products: Identify key products marketed and prescribed for Psoriasis in the US, including trade name, molecule name, and company
- Psoriasis Product Sales: Find out the sales revenues of Psoriasis products, both branded and generics, in the US
- Psoriasis Market Valuations: Find out the market size for Psoriasis products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Psoriasis Products Market Share: Find out the market shares for key Psoriasis products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Psoriasis market analysis and sales trends
- Track competitor drugs sales and market share in the US Psoriasis market
- Track competitive developments in Psoriasis market and present key issues and learnings
- Synthesize insights for Psoriasis market and products to drive business performance
- Answer key business questions about the Psoriasis market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Psoriasis products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Psoriasis Treatments
3) Psoriasis Pipeline
4) US Psoriasis Epidemiology
5) Marketed Drugs for Psoriasis in US
6) US Psoriasis Market Size
7) US Psoriasis Products Sales
8) US Psoriasis Market Competitive Landscape
9) US Psoriasis Market Forecast
10) Methodology
11) Contact us

1. Psoriasis Epidemiology, US, 2010 - 2020
2. Psoriasis Market Size ($), US, 2010 – 2015
3. Psoriasis Products Market Share (%), US, 2015
4. Psoriasis Market Forecast ($), US, 2015 – 2020

1. Psoriasis Phase 3 Clinical Trials, 2016
2. Psoriasis Phase 2 Clinical Trials, 2016
3. Psoriasis Phase 1 Clinical Trials, 2016
4. Psoriasis Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Psoriasis, US, 2016
6. Psoriasis Market Size ($), US, 2010 – 2015
7. Psoriasis Product Sales ($), US, 2010 – 2015
8. Psoriasis Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll